Symbio Pharmaceuticals Completes Early Repayment of First Unsecured Corporate Bond

TOKYO, Jul 08 (Pulse News Wire) – SymBio Pharmaceuticals Limited (4582.T) completed the early repayment of its first unsecured corporate bond allocated to EVO FUND on July 07, 2026. The bond, originally issued on August 26, 2025, had a total issuance amount of ¥1.235 billion.

As of the previous disclosure, the outstanding balance was ¥227.5 million. Since then, an additional amount of ¥227.5 million was repaid ahead of schedule, bringing the remaining balance to ¥0 as of July 07, 2026.